XML 31 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Other Undenominated Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2020   52,788,093        
Beginning balance at Dec. 31, 2020 $ 1,850,236 $ 4,580 $ 617,104 $ 1,134 $ (35,477) $ 1,262,895
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 153,185         153,185
Currency translation adjustment (60,617)       (60,617)  
Actuarial gain on defined benefit pension plan 4,266       4,266  
Amortization of cash flow hedge 113       113  
Gain on cash flow hedge 778       778  
Total comprehensive income 97,725          
Exercise of share options (in shares)   1,065,529        
Exercise of share options 118,589 $ 77 118,512      
Issue of restricted share units / performance share units (in shares)   328,634        
Issue of restricted share units / performance share units 23 $ 23        
Share based compensation expense 133,553   133,553      
Share issuance costs (853)   (853)      
Issue of shares associated with a business combination (in shares)   27,372,427        
Repurchase of ordinary shares 5,658,155 $ 1,960 5,656,195      
Replacement share-based awards issued to acquiree employees 209,399   209,399      
Ending balance (in shares) at Dec. 31, 2021   81,554,683        
Ending balance at Dec. 31, 2021 8,066,827 $ 6,640 6,733,910 1,134 (90,937) 1,416,080
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 505,304         505,304
Currency translation adjustment (89,530)       (89,530)  
Actuarial gain on defined benefit pension plan 12,657       12,657  
Amortization of cash flow hedge 0          
Gain on cash flow hedge (3,728)       (3,728)  
Total comprehensive income 424,703          
Exercise of share options (in shares)   348,286        
Exercise of share options 35,828 $ 21 35,807      
Issue of restricted share units / performance share units (in shares)   241,116        
Issue of restricted share units / performance share units 16 $ 16        
Share based compensation expense 70,606   70,606      
Share issuance costs (17)   (17)      
Repurchase of ordinary shares (in shares)   (420,530)        
Repurchase of ordinary shares (99,983) $ (28)   28   (99,983)
Share repurchase costs $ (17)         (17)
Ending balance (in shares) at Dec. 31, 2022 81,723,555 81,723,555        
Ending balance at Dec. 31, 2022 $ 8,497,963 $ 6,649 6,840,306 1,162 (171,538) 1,821,384
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 612,335         612,335
Currency translation adjustment 26,221       26,221  
Actuarial gain on defined benefit pension plan 244       244  
Amortization of cash flow hedge 0          
Gain on cash flow hedge 1,567       1,567  
Total comprehensive income 640,367          
Exercise of share options (in shares)   535,705        
Exercise of share options 50,958 $ 35 50,923      
Issue of restricted share units / performance share units (in shares)   235,826        
Issue of restricted share units / performance share units 15 $ 15        
Share based compensation expense 51,456   51,456      
Share issuance costs $ (16)   (16)      
Ending balance (in shares) at Dec. 31, 2023 82,495,086 82,495,086        
Ending balance at Dec. 31, 2023 $ 9,240,743 $ 6,699 $ 6,942,669 $ 1,162 $ (143,506) $ 2,433,719